A link between PDL1 and T regulatory cells in fetomaternal tolerance

Journal of Immunology

Volumn 179, Issue 8, 2007, Pages 5211-5219

  Habicht, Antje ^a   Dada, Shirine ^a   Jurewicz, Mollie ^a   Fife, Brian T ^b   Yagita, Hideo ^c   Azuma, Miyuki ^d   Sayegh, Mohamed H ^a   Guleria, Indira ^a,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e Department of Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN ANTIBODY; PROTEIN PDL1; UNCLASSIFIED DRUG; B7 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; PDCD1LG1 PROTEIN, MOUSE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CELL MIGRATION; CELL TRANSFER; CONTROLLED STUDY; FEMALE; FETOMATERNAL TOLERANCE; FETUS; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SURVIVAL RATE; T CELL DEPLETION; TH1 CELL; WILD TYPE; ANIMAL; C57BL MOUSE; CBA MOUSE; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; FATHER; GENETICS; IMMUNOLOGY; LYMPHOCYTE DEPLETION; METABOLISM; MOUSE MUTANT; PASSIVE IMMUNIZATION; PLACENTA; PREGNANCY; PREGNANCY OUTCOME;

ANIMALS; ANTIGENS, CD80; CELL MOVEMENT; FATHERS; FEMALE; FETUS; IMMUNE TOLERANCE; IMMUNITY, MATERNALLY-ACQUIRED; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE DEPLETION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; PEPTIDES; PLACENTA; PREGNANCY; PREGNANCY OUTCOME; T-LYMPHOCYTES, REGULATORY;

EID: 38449105902     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.8.5211     Document Type: Article

References (50)

1. Petroff, M. G. 2005. Immune interactions at the maternal-fetal interface. J. Reprod. Immunol. 68: 1-13.
2. Guleria, I., A. Khosroshahi, M. J. Ansari, A. Habicht, M. Azuma, H. Yagita, R. J. Noelle, A. Coyle, A. L. Mellor, S. J. Khoury, and M. H. Sayegh. 2005. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J. Exp. Med. 202: 231-237.
3. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
4. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168: 1080-1086.
5. Cobbold, S. P., E. Adams, L. Graca, S. Daley, S. Yates, A. Paterson, N. J. Robertson, K. F. Nolan, P. J. Fairchild, and H. Waldmann. 2006. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol. Rev. 213: 239-255.
6. Wood, K. J., and S. Sakaguchi. 2003. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3: 199-210.
7. Tafuri, A., J. Alferink, P. Moller, G. J. Hammerling, and B. Arnold. 1995. T cell awareness of paternal alloantigens during pregnancy. Science 270: 630-633.
8. Aluvihare, V. R., M. Kallikourdis, and A. G. Betz. 2004. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5: 266-271.
9. + T regulatory cells prevents fetal rejection in a murine abortion model. Am. J. Pathol. 166: 811-822.
10. + regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol. Hum. Reprod. 10: 347-353.
11. Heikkinen, J., M. Mottonen, A. Alanen, and O. Lassila. 2004. Phenotypic characterization of regulatory T cells in the human decidua. Clin. Exp. Immunol. 136: 373-378.
12. + regulatory T-cell subset. Immunology 112: 38-43.
13. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
14. + regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol. 14: 771-778.
15. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
16. + regulatory T cells. Nat. Immunol. 4: 330-336.
17. + T regulatory cells. Nat. Immunol. 4: 337-342.
18. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
19. Wan, Y. Y., and R. A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102: 5126-5131.
20. Agata, Y., H. Kawasaki, H. Nishimura, Y. Ishida, T. Tsubata, H. Yagita, and T. Honjo. 1996. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8: 765-772.
21. Vibhakar, R., G. Juan, F. Traganos, Z. Darzynkiewicz, and L. R. Finger. 1997. Activation-induced expression of human programmed death-1 gene in T-lymphocytes. Exp. Cell. Res. 232: 25-28.
22. Khoury, S. J., and M. H. Sayegh. 2004. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 20: 529-538.
23. Sharpe, A. H., and A. K. Abbas. 2006. T-cell costimulation biology, therapeutic potential, and challenges. N. Engl. J. Med. 355: 973-975.
24. Lechner, O., J. Lauber, A. Franzke, A. Sarukhan, H. von Boehmer, and J. Buer. 2001. Fingerprints of anergic T cells. Curr. Biol. 11: 587-595.
25. + resting regulatory T cells from activated T cells. J. Immunol. 176: 2808-2816.
26. Sandner, S., M. R. Clarkson, A. D. Salama, A. Sanchez-Fueyo, C. Domenig, A. Habicht, N. Najafian, H. Yagita, M. Azuma, L. A. Turka, and M. H. Sayegh. 2005. Role of programmed death-1 pathway in regulation of alloimmune response in vivo. J. Immunol. 174: 3408-3415.
27. Krupnick, A. S., A. E. Gelman, W. Barchet, S. Richardson, F. H. Kreisel, L. A. Turka, M. Colonna, G. A. Patterson, and D. Kreisel. 2005. Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J. Immunol. 175: 6265-6270.
28. Tsushima, F., H. Iwai, N. Otsuki, M. Abe, S. Hirose, T. Yamazaki, H. Akiba, H. Yagita, Y. Takahashi, K. Omura, et al. 2003. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur. J. Immunol. 33: 2773-2782.
29. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
30. + cells, and the alloreactive T cell clone size. J. Immunol. 169: 3744-3751.
31. + regulatory T cell function in alloimmunity. J. Immunol. 176: 329-334.
32. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
33. Weaver, C. T., L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.
34. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
35. + T regulatory cells suppress autoimmunity while establishing transplantation tolerance. J. Immunol. 176: 7149-7153.
36. Selenko-Gebauer, N., O. Majdic, A. Szekeres, G. Hofler, E. Guthann, U. Korthauer, G. Zlabinger, P. Steinberger, W. F. Pickl, H. Stockinger, et al. 2003. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 170: 3637-3644.
37. Aramaki, O., N. Shirasugi, T. Takayama, M. Shimazu, M. Kitajima, Y. Ikeda, M. Azuma, K. Okumura, H. Yagita, and M. Niimi. 2004. Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen. Transplantation 77: 6-12.
38. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
39. Nakae, S., A. Nambu, K. Sudo, and Y. Iwakura. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171: 6173-6177.
40. Lubberts, E., M. I. Koenders, B. Oppers-Walgreen, L. van den Bersselaar, C. J. Coenen-de Roo, L. A. Joosten, and W. B. van den Berg. 2004. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50: 650-659.
41. Loong, C. C., H. G. Hsieh, W. Y. Lui, A. Chen, and C. Y. Lin. 2002. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J. Pathol. 197: 322-332.
42. Salama, A. D., T. Chitnis, J. Imitola, M. J. Ansari, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198: 71-78.
43. + T cells and is overcome by IL-2. Eur. J. Immunol. 32: 634-643.
44. Dong, H., S. E. Strome, D. R. Salomao, H. Tamura, F. Hirano, D. B. Flies, P. C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8: 793-800.
45. high regulatory cells in human peripheral blood. J. Immunol. 167: 1245-1253.
46. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
47. Vanaudenaerde, B. M., L. J. Dupont, W. A. Wuyts, E. K. Verbeken, I. Meyts, D. M. Bullens, E. Dilissen, L. Luyts, D. E. Van Raemdonck, and G. M. Verleden. 2006. The role of interleukin-17 during acute rejection after lung transplantation. Eur. Respir. J. 27: 779-787.
48. Afzali, B., G. Lombardi, R. I. Lechler, and G. M. Lord. 2007. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 148: 32-46.
49. Munn, D. H., M. Zhou, J. T. Attwood, I. Bondarev, S. J. Conway, B. Marshall, C. Brown, and A. L. Mellor. 1998. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191-1193.
50. Mellor, A. L., J. Sivakumar, P. Chandler, K. Smith, H. Molina, D. Mao, and D. H. Munn. 2001. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2: 64-68.